Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN‐1)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.